Pegylated carfilzomib compounds
US11077198B2 · kind B2 · utility
0Cited by
1References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 23, 2020 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Apr 23, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G2230/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of treating multiple myeloma using polymeric pegylated carfilzomib compounds, and pharmaceutically acceptable salts thereof, of Formula I wherein R1, R2, linker, PEG, n and o are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.